We are seeking a strategically adept, respected, internationally experienced, deadline-driven and proactive individual to lead the successful development, and approval, of a pipeline of therapeutic assets and companion diagnostics for rare and speciality diseases.
This role is a key part of the growth strategy for this rapidly expanding business as they move into areas of unmet medical need and launch new therapeutics and companion diagnostics internationally. Candidates are required to have a network of high-level contacts across companion diagnostics, biomarkers and market access and comprehensive knowledge of the approval processes and systems in multiple international markets. They should have a prior track record of coordinating large project teams, identifying internal and external resources and delivering the strategy on time and to budget.
The right individual will work closely with all members of the compound development team which includes, clinical, pre-clinical development, commercial, regulatory, market access and be responsible for the biomarker and companion diagnostic (CDx) development strategy. The role will include leadership of the relevant workstreams within the market access team and you will be part of the leadership team for this functional area. The ideal candidate will have strong technical and strategic abilities, gravitas and excellent negotiation skills.